Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Quality Improvement in Pediatric Endocrinology fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    Topical Hemostasis in Minimally Invasive Surgery
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Advances in Immuno-Oncology Therapy in Urothelial Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    IBD Fellow Training in US
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal Cancer
    Release Date:
    Partner: ACCC
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Imaging Diagnostics for Differentiating Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown Cause
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Improving Treatment Environment for Chronic Myeloid Leukemia (CML)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Atrial Fibrillation and Venous Thromboembolism (excluding United States)
    Release Date:
    Partner: BMS
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom
    China Breast Cancer Landscape – Educational Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China